11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

著者: David Cameron, Martine Piccart, Richard D. Gelber, Marion Procter, Aron Goldhirsch, Evandro de Azambuja, Gilberto de Castro, Michael Untch, Ian Smith, Luca Gianni, José Baselga, N. Al-Sakaff, Sabine Lauer, Eleanor McFadden, Brian Leyland‐Jones, Richard H. Bell, Mitch Dowsett, Christian Jackisch - The Lancet 2017 被引用: 1,041